---
title: "The EU Commission Proposes a General Reform of Pharmaceutical Legislation – What it Means for Patients and the Industry"
description: "The EU Commission is proposing a general reform of pharmaceutical legislation. Read more about what this means for patients and the industry."
url: https://qbdgroup.com/en/blog/revision-of-the-eu-general-pharmaceutical-legislation
type: "Blog post"
language: en
published: 2023-05-05
author: "Koen Laenen"
category: "Regulatory Affairs"
publisher: "QbD Group"
citation: "QbD Group, \"The EU Commission Proposes a General Reform of Pharmaceutical Legislation – What it Means for Patients and the Industry\", https://qbdgroup.com/en/blog/revision-of-the-eu-general-pharmaceutical-legislation"
---
# The EU Commission Proposes a General Reform of Pharmaceutical Legislation – What it Means for Patients and the Industry
> The EU Commission is proposing a general reform of pharmaceutical legislation. Read more about what this means for patients and the industry.

## Regulatory Affairs plays a key role in the pharmaceutical industry: from drug development to commercialization. QbD's regulatory team supports clients with large and small molecule products and the more complex ATMPs of both innovative and generic drug manufacturers to ensure that their medicinal product dossier is compiled with great accuracy and registrations are submitted and followed until the end of the procedure. Need support?
---
Source: https://qbdgroup.com/en/blog/revision-of-the-eu-general-pharmaceutical-legislation — © QbD Group. Quote freely with attribution and a link back.